• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Veraxa Biotech AG - Ordinary Shares (NQ:VRXA)

    1.725 -0.155 (-8.24%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 966,173
    Open 1.840
    Bid (Size) 1.800 (500)
    Ask (Size) 1.850 (1,300)
    Prev. Close 1.880
    Today's Range 1.700 - 1.850
    52wk Range 1.700 - 27.36
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals
    Via Investor Brand Network
    InvestorNewsBreaks – Xlife Sciences AG (SIX: XLS) Shareholders Approve All Annual Meeting Proposals
    Via Investor Brand Network

    Performance

    YTD
    -93.0%
    -93.0%
    1 Month
    -93.0%
    -93.0%
    3 Month
    -93.0%
    -93.0%
    6 Month
    -93.0%
    -93.0%
    1 Year
    -93.0%
    -93.0%

    More News

    Read More
    VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline
    Via Investor Brand Network
    BillionDollarBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline
    Via Investor Brand Network
    VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’
    Via Investor Brand Network
    News headline image
    VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
    From VERAXA Biotech GmbH
    Via GlobeNewswire
    BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
    Via Investor Brand Network
    MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
    Via Investor Brand Network
    BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform
    Via Investor Brand Network
    News headline image
    VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
    From VERAXA Biotech GmbH
    Via GlobeNewswire
    InvestorNewsBreaks – Why VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’
    Via Investor Brand Network
    BioMedNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Completes Business Combination and Begins Trading on Nasdaq
    Via Investor Brand Network

    Frequently Asked Questions

    Is Veraxa Biotech AG - Ordinary Shares publicly traded?
    Yes, Veraxa Biotech AG - Ordinary Shares is publicly traded.
    What exchange does Veraxa Biotech AG - Ordinary Shares trade on?
    Veraxa Biotech AG - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Veraxa Biotech AG - Ordinary Shares?
    The ticker symbol for Veraxa Biotech AG - Ordinary Shares is VRXA on the Nasdaq Stock Market
    What is the current price of Veraxa Biotech AG - Ordinary Shares?
    The current price of Veraxa Biotech AG - Ordinary Shares is 1.725
    When was Veraxa Biotech AG - Ordinary Shares last traded?
    The last trade of Veraxa Biotech AG - Ordinary Shares was at 07/01/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.